WAY100635-induced augmentation of the 5-HT-elevating action of citalopram: Relative importance of the dose of the 5-HT(1A) (Auto)receptor blocker versus that of the 5-HT reuptake inhibitor

Neuropharmacology

Volumn 36, Issue 4-5, 1997, Pages 461-465

  Hjorth, S ^a   Westlin, D ^a   Bengtsson, H J ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

5 HT; 5 HT reuptake inhibition; 5 HT(1A) autoreceptor blockade; 5 HT(1A) receptor; Citalopram; In vivo microdialysis; WAY100635

Indexed keywords

AUTORECEPTOR; CITALOPRAM; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN; SEROTONIN 1A ANTAGONIST; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIALYSATE; DOSE TIME EFFECT RELATION; DRUG POTENTIATION; FOREBRAIN; HIPPOCAMPUS; MALE; MESENCEPHALON; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAPHE NUCLEUS; RAT; SEROTONIN RELEASE; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; CITALOPRAM; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SPACE; HIPPOCAMPUS; MALE; MICRODIALYSIS; PIPERAZINES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0030990480     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(97)00050-6     Document Type: Article

References (35)

1. Adell A. and Artigas F. (1991) Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex, an in vivo brain microdialysis study. Naunyn-Schmiedeberg's Archives of Pharmacology 343: 237-244.
2. 1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram. Naunyn-Schmiedeberg's Archives of Pharmacology 352: 157-165.
3. 1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram. Naunyn-Schmiedeberg's Archives of Pharmacology 353: 630-640.
4. Artigas F., Romero L., Celada P. and Bel N. (1994a) Pindolol induces a rapid improvment of depressed patients treated with serotonin reuptake inhibitors. Archives of General Psychiatry 51: 248-251.
5. 1A antagonists and terminal 5-HT release. Effects of combined treatment with 5-HT uptake inhibitors. Society for Neuroscience Abstracts 20: 1541.
6. Auerbach S. B., Lundberg J. F. and Hjorth S. (1995) Differential inhibition of serotonin release by 5-HT and NA reuptake blockers after systemic administration. Neuropharmacology 34: 89-96.
7. Bel N. and Artigas F. (1992) Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei, an in vivo microdialysis study. European Journal of Pharmacology 229: 101-103.
8. Blier P. and Bergeron R. (1995) Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. Journal of Clinical Psychopharmacology 15: 217-222.
9. Chaput Y., De Montigny C. and Blier P. (1986) Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain. Naunyn-Schmiedeberg's Archives of Pharmacology 333: 342-348.
10. 1A receptors. Neurochemical Research 21: 557-562.
11. 1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135. Journal of Pharmacology and Experimental Therapeutics 278: 752-762.
12. 1A receptor antagonist, WAY-100635. European Journal of Pharmacology 281: 81-88.
13. Fuller R. W. (1994) Minireview: uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sciences 55: 163-167.
14. 1A autoreceptors. Anxiety 3: 149-152.
15. 1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. British Journal of Pharmacology 115: 1064-1070.
16. Gundlah, C., Hjorth, S. and Auerbach, S. (1997) Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment. Neuropharmacology 36(4/5): 475-482.
17. 1A antagonist in determined by arousal state. Journal of Psychopharmacology. 8 (Suppl.), A13 (abstr. 50).
18. Hajós M., Gartside S. E. and Sharp T. (1995) Inhibition of median and dorsal raphe neurones following administration of the selective serotonin reuptake inhibitor paroxetine. Naunyn-Schmiedeberg's Archives of Pharmacology 351: 624-629.
19. Hajós M., Gartside S. E. and Sharp T. (1995) Evidence for a repetitive (burst) firing pattern in a sub-population of 5-hydroxytryptamine neurons in the dorsal and median raphe nuclei of the rat. Neuroscience 69: 189-197.
20. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo, a microdialysis study. Journal of Neurochemistry 60: 776-779.
21. Hjorth S. (1996) (-)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-HT. European Journal of Pharmacology 303: 183-186.
22. 1A autoreceptors in the action of selective serotonin reuptake inhibitors. European Journal of Pharmacology 260: 251-255.
23. 1A receptors or β-adrenoceptors, restrain the citalopram-induced increase in extracellular 5-HT in vivo. European Journal of Pharmacology 316: 43-47.
24. 1B autoreceptor blocking properties of the beta-adrenoceptor antagonist (-)-penbutolol. Journal of Pharmacology and Experimental Therapeutics 265: 707-712.
25. 1A receptors in rat brain. European Journal of Pharmacology 271: 515-523.
26. Invernizzi R., Belli S. and Samanin R. (1992) Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex. Brain Research 584: 322-324.
27. 1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunun-Schmiedeberg's Archives of Pharmacology 352: 141-148.
28. Malagié I., Trillat A. C., Doucet E., Laporte A. M., Hamon M. and Lanfumey L. (1996) Regional differences in the effect of the combined treatment of WAY 100635 and fluoxetine: An in vivo microdialysis study. Naunyn-Schmiedeberg's Archives of Pharmacology 352: 1-6.
29. McQuade, R. (1996) In vivo neurochemical studies comparing dorsal and median raphé 5-HT pathways. Ph.D. thesis. Departments of Clinical Pharmacology and Psychiatry, Wadham College, University of Oxford.
30. 1A antagonists WAY100135 and WAY100635, on guinea-pig behaviour and dorsal raphe 5-HT neurone firing. British Journal of Pharmacology 117: 750-756.
31. 1A receptor antagonist (S)-UH-301 prevents (R)-8-OH-DPAT-induced decrease in interstitial concentrations of serotonin in the rat hippocampus. European Journal of Pharmacology 216: 373-378.
32. Paxinos, G. and Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates. 2nd Edn. Academic Press, San Diego.
33. 1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain. Neuropsychopharmacology 15: 349-360.
34. Rutter J. J., Gundlah C. and Auerbach S. B. (1995) Systemic uptake inhibition decreases serotonin release via somatodendritic autoreceptor activation. Synapse 20: 225-233.
35. Sharp T., Bramwell S. R., Hjorth S. and Grahame-Smith D. G. (1989) Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis. British Journal of Pharmacology 98: 989-997